Beyond application, the market taxonomy distinguishes test Types that affect adoption rates and pricing structures. Saliva‑based kits dominate due to ease of collection, representing the bulk of consumer‑grade offerings; they are typically priced for the mass market and generate high volume sales. Blood‑based kits, while less common, are preferred for clinical accuracy and are often bundled with veterinary diagnostics, yielding higher per‑unit revenue. Comprehensive panels combine breed, health, ancestry, and behavior markers into a single assay, targeting premium segments that accept higher costs for integrated insights. Single‑gene tests focus on specific hereditary conditions, serving both veterinarians and owners with targeted health concerns; these have a niche but high‑margin profile. Each type contributes uniquely to the total market, with saliva kits driving volume, blood kits and comprehensive panels enhancing average selling price, and single‑gene tests reinforcing specialized demand within the broader Cat DNA Test market.